Keyphrases
P38 Mitogen-activated Protein Kinase (p38 MAPK)
100%
Hepatic Steatosis
100%
Toll-like Receptor 4 (TLR4)
100%
Lipotoxicity
100%
Induced Hepatocytes
100%
Sirtuin 1 (SIRT1)
100%
Hepatocyte Injury
100%
Cimifugin
100%
Palmitate
58%
Protective Effect
25%
Hepatocytes
25%
Knockdown
16%
Oleate
16%
Hepatoprotective
16%
SIRT1 Signaling
16%
Inflammation
8%
Oxidative Stress
8%
Cytotoxicity
8%
Dose Effect
8%
Induced Cell Death
8%
Small Interfering RNA (siRNA)
8%
Mitochondrial Damage
8%
Biological Properties
8%
Disease Pathogenesis
8%
Hepatotoxicity
8%
Lipid Accumulation
8%
ERK2
8%
AMPK Pathway
8%
Metabolic Disorders
8%
Steatosis
8%
P38 MAPK Pathway
8%
Allergy
8%
Oxidative Stress Damage
8%
Mouse Hepatocytes
8%
Coumarin Derivatives
8%
Metabolic-associated Fatty Liver Disease (MAFLD)
8%
Hepatocyte Cell Line
8%
Hepatic Lipotoxicity
8%
SIRT1 Expression
8%
Steatosis Model
8%
CLI-095
8%
TLR4 Agonist
8%
TLR4 Antagonist
8%
Saposhnikovia Divaricata
8%
Hepatocellular Injury
8%
P38 MAPK Activation
8%
Cell Steatosis
8%
Hepatic Metabolic Disorder
8%
Pharmacology, Toxicology and Pharmaceutical Science
Toll Like Receptor 4
100%
Steatosis
100%
Lipotoxicity
100%
Palmitic Acid
63%
Oleic Acid
18%
Cytotoxicity
9%
Inflammation
9%
Small Interfering RNA
9%
Metabolic Disorder
9%
Fatty Liver
9%
Hepatotoxicity
9%
Mitogen Activated Protein Kinase 3
9%
Coumarin Derivative
9%
Liver Cell Damage
9%